Ahmedabad-based Torrent Pharmaceuticals jumped 12.45 per cent to close at Rs 174.35 on reports that Vadodara-based Sun Pharmaceuticals is eyeing a substantial stake in the company.

<tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>However, both the companies have denied such reports. While Torrent has clarified that its promoters do not intend to sell stake to Sun, the latter maintained that it is not looking for any domestic acquisition. 
</p><p class='TableClas'>The stock hit an intraday high of Rs 182.15 and a low of Rs 158 on Tuesday. It bounced back after hitting a 52-week low of Rs 120.05 on June 9. </P></p><p class='TableClas'></p></table>


Torrent jumps on stake sale buzz

DALAL STREET SPIKES

More From This Section

Idea shares fall after Q3 earnings disappoint

BofA-Merrill raises Indiabulls to 'buy', stock gains

Suzlon stocks jump 17% on CDR approval

Maruti Suzuki rallies as Q3 profit beats analyst's estimates

Explore News